These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 8230751)

  • 1. [Clinical characteristics and treatment results of acute promyelocytic leukemia in children (Children's Cancer and Leukemia Study Group)].
    Shimizu H; Nakadate H; Taga T; Utsumi J; Nishikawa K; Gushiken T; Horikoshi Y; Oka T; Kikuta A; Maeda H
    Rinsho Ketsueki; 1993 Sep; 34(9):989-96. PubMed ID: 8230751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience].
    Rolovitsh Z; Cholovitsh M; Elezovitsh I; Vidovitsh A; Radoshevitsh-Radojkovitsh N; Boshkovitsh D; Novak A; Basara N
    Srp Arh Celok Lek; 1995; 123(11-12):279-85. PubMed ID: 16296239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Long-term follow-up of treatment outcome and prognosis on 46 children with acute promyelocytic leukemia].
    Xu XJ; Shi SW; Tang YM; Song H; Yang SL; Wei J; Xu WQ; Pan BH; Chen YH; Zhao FY; Shen HQ; Qian BQ; Zhang LY; Ning BT
    Zhongguo Dang Dai Er Ke Za Zhi; 2007 Feb; 9(1):28-33. PubMed ID: 17306073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment with all-trans retinoic acid and anthracycline monochemotherapy for children with acute promyelocytic leukemia: a multicenter study by the PETHEMA Group.
    Ortega JJ; Madero L; Martín G; Verdeguer A; García P; Parody R; Fuster J; Molines A; Novo A; Debén G; Rodríguez A; Conde E; de la Serna J; Allegue MJ; Capote FJ; González JD; Bolufer P; González M; Sanz MA;
    J Clin Oncol; 2005 Oct; 23(30):7632-40. PubMed ID: 16234524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A survival study and prognostic factors analysis on acute promyelocytic leukemia at a single center.
    Xin L; Wan-jun S; Zeng-jun L; Yao-zhong Z; Yun-tao L; Yan L; Chang-chun W; Qiao-chuan L; Ren-chi Y; Ming-zhe H; Jian-xiang W; Lu-gui Q
    Leuk Res; 2007 Jun; 31(6):765-71. PubMed ID: 17007927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapy of acute promyelocytic leukemia in Czechia: results and analysis of prognostic factors].
    Schwarz J; Korístek Z; Starý J; Zák P; Kozák T; Marková J; Michalová K; Dvoráková D; Mayer J; Cetkovský P
    Vnitr Lek; 2008; 54(7-8):757-70. PubMed ID: 18780575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Childhood acute promyelocytic leukemia: no benefit of all-trans-retinoic acid administered in a short-course schedule.
    Zubizarreta PA; Rose AB; Felice MS; Alfaro E; Delfino S; Cygler AM; Sackmann-Muriel F
    Pediatr Hematol Oncol; 2000 Mar; 17(2):155-62. PubMed ID: 10734658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term survival and prognostic study in acute promyelocytic leukemia treated with all-trans-retinoic acid, chemotherapy, and As2O3: an experience of 120 patients at a single institution.
    Hu J; Shen ZX; Sun GL; Chen SJ; Wang ZY; Chen Z
    Int J Hematol; 1999 Dec; 70(4):248-60. PubMed ID: 10643151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Additional cytogenetic changes do not influence the outcome of patients with newly diagnosed acute promyelocytic leukemia treated with an ATRA plus anthracyclin based protocol. A report of the Spanish group PETHEMA.
    Hernández JM; Martín G; Gutiérrez NC; Cervera J; Ferro MT; Calasanz MJ; Martínez-Climent JA; Luño E; Tormo M; Rayón C; Díaz-Mediavilla J; González M; González-San Miguel JD; Pérez-Equiza K; Rivas C; Esteve J; Alvarez Mdel C; Odriozola J; Ribera JM; Sanz MA;
    Haematologica; 2001 Aug; 86(8):807-13. PubMed ID: 11522536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome of childhood acute promyelocytic leukemia with all-trans-retinoic acid and chemotherapy.
    de Botton S; Coiteux V; Chevret S; Rayon C; Vilmer E; Sanz M; de La Serna J; Philippe N; Baruchel A; Leverger G; Robert A; San Miguel J; Conde E; Sotto JJ; Bordessoule D; Fegueux N; Fey M; Parry A; Chomienne C; Degos L; Fenaux P
    J Clin Oncol; 2004 Apr; 22(8):1404-12. PubMed ID: 15084614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Acute promyelocytic leukemias: clinico-biological aspects, prognostic factors, therapeutic response, and possibilities of cure in 34 cases (1970-1988)].
    Sánchez Fayos J; Outeiriño J; de Villalobos E; Prieto E; Bernacer M; Calabuig T; Benítez J; Pérez Saenz MA; Rodríguez C; Paniagua C
    Sangre (Barc); 1990 Feb; 35(1):33-40. PubMed ID: 2185563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of acute promyelocytic leukemia relapse in the ATRA era.
    Castagnola C; Lunghi M; Corso A; Tajana M; Zappasodi P; Dabusti M; Lazzarino M; Bernasconi C
    Haematologica; 1998 Aug; 83(8):714-7. PubMed ID: 9793255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. All-transretinoic acid and chemotherapy in the treatment of acute promyelocytic leukemia.
    Al Bahar S; Pandita R; Bavishi K; Kreze O
    Indian J Cancer; 2004; 41(3):125-8. PubMed ID: 15472411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is cytarabine useful in the treatment of acute promyelocytic leukemia? Results of a randomized trial from the European Acute Promyelocytic Leukemia Group.
    Adès L; Chevret S; Raffoux E; de Botton S; Guerci A; Pigneux A; Stoppa AM; Lamy T; Rigal-Huguet F; Vekhoff A; Meyer-Monard S; Maloisel F; Deconinck E; Ferrant A; Thomas X; Fegueux N; Chomienne C; Dombret H; Degos L; Fenaux P;
    J Clin Oncol; 2006 Dec; 24(36):5703-10. PubMed ID: 17116939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment results in childhood acute myeloblastic leukemia--a report of clinical trials of a past decade from the Japanese children's Cancer and Leukemia Study Group (CCLSG)].
    Tsurusawa M; Katano N; Hirota T; Mimaya J; Horikoshi Y; Kawamura N; Yanai M; Kamitamari A; Tsuji Y; Fujimoto T
    Rinsho Ketsueki; 1997 Jun; 38(6):505-12. PubMed ID: 9248326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe hemorrhagic complications during remission induction therapy for acute promyelocytic leukemia: incidence, risk factors, and influence on outcome.
    Yanada M; Matsushita T; Asou N; Kishimoto Y; Tsuzuki M; Maeda Y; Horikawa K; Okada M; Ohtake S; Yagasaki F; Matsumoto T; Kimura Y; Shinagawa K; Iwanaga M; Miyazaki Y; Ohno R; Naoe T
    Eur J Haematol; 2007 Mar; 78(3):213-9. PubMed ID: 17241371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Results of the CCLSG high risk ALL 874 protocol in childhood acute lymphoblastic leukemia. Children's Cancer and Leukemia Study Group].
    Kawai S; Fujimoto T; Zha Z; Asami K; Oka T; Kaneko Y; Takaue Y; Ninomiya T; Nishikawa K; Tsuchiya T
    Rinsho Ketsueki; 1993 Feb; 34(2):128-36. PubMed ID: 8492409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effectiveness of trans-retinoic acid in the treatment of acute promyelocytic leukemia: initial results of a multicenter study].
    Parovichnikova EN; Savchenko VG; Kliasova GA; Isaev VG; Demidova IA; Ol'shanskaia IuV; Tiurina NG; Tikhonova LIu; Galstian GM; Pivnik AV
    Ter Arkh; 1999; 71(7):20-4. PubMed ID: 10481862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Myelogenous leukemia in children. ANLL9205 study by Children's Cancer and Leukemia Study Group (CCLSG)].
    Mimaya J; Horikoshi Y; Shimizu H; Maeda H; Koizumi S; Kawakami K; Watanabe A; Utsumi J; Kikuta A; Oka T; Mugishima H; Kawamura N; Gushiken T; Ohta S; Yamamura Y; Ishida Y; Sekine I; Okada N; Fujimoto T
    Rinsho Ketsueki; 1997 Feb; 38(2):100-7. PubMed ID: 9059063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of risk factors for fatal hemorrhage during induction therapy of patients with acute promyelocytic leukemia.
    Ventura GJ; Hester JP; Dixon DO; Khorana S; Keating MJ
    Hematol Pathol; 1989; 3(1):23-8. PubMed ID: 2745357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.